-+ 0.00%
-+ 0.00%
-+ 0.00%

HOOKIPA PHARMA INC - PHASE 1B TRIAL EVALUATING SAFETY AND IMMUNOGENICITY OF HB-500

Reuters·01/30/2025 12:00:00

Please log in to view news